小干扰RNA的设计及原理

!#!$!%&!%!’()*+),-./,-!#!$!%&!%!012%!1&32421%#25&67/--/898:80;7:,,=,6?8@:,AB9CA/*D/E@A,+8@/,EFG?HI)*/67-*C,AE/E012%=IA7+87@*9@8+*E@D,A+,@,A7-+*JA**K,AA*9L,E+/EJ78@:,AMNOP8:8Q*-34&!1&32421%#25&67/--/&898:80;7:,,=,6RH?0!0’20%!’20%’RH?RH?9/RH?9/RH?9/RH?RH?RH?’RH?RH?’S23!!#$%&’(#$)*+(’,-(($.$&/0&123.$($.4&5$6$/$’&’(70,%/8&-93,##$’&$&:0;;0$0&=#FG?HI)*/0MNOP8:8!!#$%&’(#)’*+,%’-*.*/0’-#1#2*)34*5$6’%.76%)86%*’*)/9)6:#&56’076%);!=-6)%?#$%&’(#)’*+4#(%’*.*/0’-#1#2*)34*5$6’%.76%)86%*’*)/9)6:#&56’076%);!=-6)%+6#/,0./’RH?/E@*AD*A*E*@*:E/T8*:79C**EA*U,-8@/,E/V/EJD8E@/,E7-J*E,6/9+A8J@7A&J*@/+*E@/D/7@/,E7E+U7-/+7@/,E=?E+@:*7A*L,@*E@/7--U7-87C-*/E-/E/7-LA7@/*=WE-X*--&+*&9/JE*+9/RH?7E9L*/D/7--7E+*DD//*E@-/E:/C/@@:**YLA*99/,E,D@:*@7AJ*@J*E*9=Q:/97A@/-*A*U/*X9@:*D*7@8A*9,D9/RH?9*T8*E*9LA/E/L-*97E+6*:7E/969,D9/RH?+*9/JE7E+@:**Y&L*A/6*E@7-9@A7@*J/*9@*9@/EJ,D@:**DD//*E7E+9L*/D//@,DRH?/E@*AD*A*E*@,LA,U/+*/ED,A&67@/,ED,A@:*X/+*A7LL-/7@/,E,DRH?/E@*AD*A*E*@*:E/T8*=?@’,1#ARH?/E@*AD*A*E*9/RH?9*T8*E*+*9/JE’’RH?/9/R&H?9/RH?!#Z9/RH?RH?/BA#$)*+#9/RH???6RH?#[0CL#[0CL??H019/RH??6C/,E9/RH?@7AJ*@D/E+*A??H01??9/RH?OO09/R&H???I9/RH?9/RH?RH?I%Q%?L,-!%[4Q%Q%?!#$%&’()*+’()*+)*+)*+)*+,)*+’()*+,)*+-)*+.)*+/)*+()0&12$%3’!)*+(’()*+,)*+’()*+)*+()*+(,)*+,)*+)*+(’()*+,)*+4’()*+)*+()*+(’()*+56)*+(!657’()*+!,)*+’()*+’’()*+!6’()*+’()*+)*+(!#$%&’()0&1$%3’!’()*+8’()*+8!-9!:;5/;!6=5=+-?@!!+-?@#’()*+?,?,/:;$=+%!+&=:@’=9(=!457’()*+’()*+=/!’()*+’()*+)*+)AB98=!457=C8=/!6=5=+@=7’()*+’()*+)0&1$%3’!=8:’()*+=5D5;’()*+7’()*+5:;/D;8:;7’()*+=C;5:;E=5:;7’()*+)*+()*+(4’()*+)AB9)AB9?,’()*+’()*+-9’()*+)AB9-9’()*+-9’()*+!6+-?@5F’()*+)AB9)*+(=:@’()*+)AB956=:==)*+)AB9@!69+-=:@)AB9@!6)%&’$’()*+,)*+’()*+’()2*+=4//::5/!/4:2/4/GHI03I$%J($%/::5/!/4:2/4/!#$%&’()*+,-*+./01’()*+#)*+./01./201)01’()*+’()*+)*+(#(,%3$%%$4’()*+!#$%&’()*+)*+()*+(’()*+5!’()*+67899:;7)*+#()*+’()*+##)*+’()*+’()*+’()*+’()*+6686=6’()*+66’()*+?@+AB’()*+6C86&’()*+)*+(!’()2*+689’()*+’()*+’()*+?@+AB’()2*+#’()*+’()*+)*+(’()*+)*+(6D.E:$’F(%AGG$%H(IJKL1$HM$I(3N’M$+!#$O0I,H(3I$E$I$H3#43P’()*+P3%#JQ($H(IRJPP(,(JIH)*+((I-%3’3;F(2E$#JE$I3R$’HJ%J#:%43E4’$HJO.G?SL969C&&2O9D@JJ*A-3FT(#$B?$J%/!#$O.U;%J’’(3I3P’#$EE(I2HJ%PJ%(IR)*+’H$%RJHJQ$R$(I’HVWX26%JYH%$I’,%(;H’(IF2#$I,JEE’O*$H%J?(3HJ,F999=2=O5D)J4I3EQ’+@J$MJ-?3J’JZ!#$O)$H(3I$E’()*+QJ’(RIP3%)*+(IHJ%PJ%JI,JO*$H%J?(3HJ,F9[9959C25O[D-(IR\@$N%JI,J].O+’H$H(’H(,$E’$#;E(IR$ER3%(HF#P3%)*+’J,3IQ$%4’H%,H%J;%JQ(,H(3IO*,EJ(,+,(Q’)J’9556&9256O=D+#$%KR(3(GV3EJIB?$:$(J.!#$OB3EJ%$I,JP3%#2H$H(3I’$IQ,FJ#(,$E#3Q(P(,$H(3I’(I$’()*+O*,EJ(,+,(Q’)J’95569=727=OCDV$#$Q$GSFH’M$B!$#$(Q$)!#$O.PPJ,H’3I)*+(IHJ%PJ%JI,J(IRJIJJU;%J’’(3I)*+((I,EH%JQ#$#2#$E($I,JEE’3P#(’#$H,FJ’$IQHFJ(IH%3Q,H(3I3P,FJ#(,$E#3Q(P(,$H(3I’$HHFJ5^2JIQ’3P’()*+’O+IH(’JI’J*,EJ(,+,(Q-%R-JY9969=5627O&D!#$%)]3IME(I-AG(HH$EXOV(RF2HF%3RF;H’JEJ,H(3I3PJPPJ,H(YJ)*+(;%3:J’P3%RJIJ’(EJI,(IRO/JI3#J)J’956595552[ODAEJQK]+V3EM3GQJXJJ%GL!#$O+,H(Y$H(3I3PHFJ(I2HJ%PJ%3I’4’HJ#:4’F3%H2(IHJ%PJ%(IR)*+’O*$H%J]JEE?(3E95=5[27O7D?%(QRJ+L1J:J%I$%QA-,%$U+!#$OWIQ,H(3I3P$I(IHJ%PJ%3I%J’;3I’J:4)*+(YJ,H3%’(I#$##$E($I,JEE’O*$H%J/JIJH955[9C52[O6DL$,M’3I+@?$%HKA)A,FJEHJ%L!#$O.U;%J’’(3I;%3P(E(IR%JYJ$E’3PP2H$%RJHRJIJ%JRE$H(3I:4)*+(O*$H%J?(3HJ,FI23E9596C5=2&O66DA,$,FJ%(1])3KJI:E$HH2)3’JIS]$;EJI*L!#$OAF3%H(IHJ%PJ%(IR)*+’,$I(IQ,JIJU;J,HJQ$IQQ(YJ%RJIH,F$IRJ’(IHFJEJYJE’3PIH$%RJHJQ;%3HJ(I’(I#$##$E($I,JEE’O1%3,*$HE+,$QA,(_A+9[666792&O9[26629=9[9‘)*+小干扰RNA的设计及原理作者：张镁，刘苏虎，ZHANGMei，LiuSuhu作者单位：张镁,ZHANGMei(西安交通大学第二医院病理科,西安市,710004)，刘苏虎,LiuSuhu(西安交通大学第二医院血液科,西安市,710004)刊名：医学分子生物学杂志英文刊名：JOURNALOFMEDICALMOLECULARBIOLOGY年，卷(期)：2005，2(3)引用次数：1次参考文献(11条)1.ElbashirSM.MartinezJ.PatkaniowskaAFunctionalanatomyofsiRNAformediatingefficientRNAiinDrosophilamelanogasterembryolysate20012.LeeNS.DohjimaT.BauerGExpressionofsmallinterferingRNAstargetedagainstHIV-1revtranscriptsinhumancells20023.ReynoldsA.LeakeD.BoeseQRationalsiRNAdesignforRNAinterference20044.DingY.LawrenceCEAstatisticalsamplingalgorithmforRNAsecondarystructureprediction20035.AmarzguiouiM.HolenT.BabaieEToleranceformutationsandchemicalmodificationsinasiRNA2003(2)6.HamadaM.OhtsukaT.KamaidaREffectsonRNAinterferenceingeneexpression(RNAi)inculturedmammaliancellsofmismatchesandtheintroductionofchemicalmodificationsatthe3'-endsofsiRNAs20027.KumarR.ConklinDS.MittalVHigh-throughputselectionofeffectiveRNAiprobesforgenesilencing20038.SledzCA.HolkoM.deVeerMJActivationoftheinterferonsystembyshort-interferingRNAs20039.BridgeAJ.PebernardS.DucrauxAInductionofaninterferonresponsebyRNAivectorsinmammaliancells200310.JacksonAL.BartzSR.SchelterJExpressionprofilingrevealsoff-targetgeneregulationbyRNAi200311.ScacheriPC.Rozenblatt-RosenO.CaplenNJShortinterferingRNAscaninduceunexpectedanddivergentchangesinthelevelsofuntargetedproteinsinmammaliancells2004相似文献(10条)1.期刊论文史毅.金由辛.SHIYi.JINYou-xinRNA干扰与siRNA(小干扰RNA)研究进展-生命科学2008,20(2)RNA干扰作为后基因组时代的一种下调基因表达的工具已被广泛用于基因功能的研究以及疾病的治疗.在RNA干扰技术下调基因表达的背后存在着一个复杂的蛋白质网络参与了这一功能的实现.本文对近年来RNA干扰在疾病治疗方面的进展及其机制研究方面的进展作了一些概述.2.学位论文祝蓉采用R